Tempest Therapeutics, Inc. (TPST) Total liabilities 2016–2017
Tempest Therapeutics, Inc. (TPST) total liabilities at each fiscal year-end, per SEC filings.
$4.8MFY2017 · since FY2016: $14.3M → $4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | $4.8M | -66.3% |
| FY2016 | $14.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TPST financial trends
TPST RevenueTPST Net incomeTPST Net marginTPST Gross profitTPST Gross marginTPST Operating incomeTPST Operating marginTPST Operating cash flowTPST Free cash flowTPST Capital expendituresTPST Return on equityTPST Stock buybacksTPST Dividends paidTPST Total assetsTPST Shareholders’ equityTPST overview →